Human immunoglobulins produced in hu-PBL-SCID mice are polyclonal early after xenotransplantation

Détails

ID Serval
serval:BIB_E56D460F73AA
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Institution
Titre
Human immunoglobulins produced in hu-PBL-SCID mice are polyclonal early after xenotransplantation
Périodique
Cellular Immunology
Auteur⸱e⸱s
Tissot  J. D., Schneider  P., Schapira  M., Duchosal  M. A.
ISSN
0008-8749
Statut éditorial
Publié
Date de publication
02/1996
Peer-reviewed
Oui
Volume
167
Numéro
2
Pages
241-248
Langue
anglais
Notes
Journal Article Research Support, Non-U.S. Gov't --- Old month value: Feb 1
Résumé
Xenotransplantation of human peripheral blood leukocytes (hu-PBL) to severe combined immune-deficient (SCID, hu-PBL-SCID) mice leads to human immunoglobulin (Ig) production in the animals. Here we used a sensitive high-resolution two-dimensional electrophoresis (2D-PAGE) technique to separate, and to analyze, Ig gamma and light chains in sera from SCID mice given hu-PBL for less than 35 days. Human Igs in the model appeared polyclonal until 3 weeks after cell transfer. After this period, oligoclonal Igs progressively replaced this polyclonal background. The 2D-PAGE pattern evolution of human Igs was similar when hu-PBL originated from donors with or without previous contact with the Epstein-Barr virus. The broad diversity of human Igs, and therefore the large expressed B cell repertoire, in hu-PBL-SCID mice during a period that allows manipulation (such as immunization) of the human graft has evident implication for the use of this model in the generation of specific antibodies of desired specificity.
Mots-clé
Animals *Antibody Formation Blood Proteins/chemistry Clone Cells Electrophoresis, Gel, Two-Dimensional Humans Immunoglobulin G/chemistry Immunoglobulin Light Chains/chemistry *Lymphocyte Transfusion Mice *Mice, SCID Time Factors Transplantation, Heterologous
Pubmed
Web of science
Création de la notice
19/01/2008 18:30
Dernière modification de la notice
20/08/2019 17:08
Données d'usage